Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies

ClinicalTrials.gov ID: NCT02594124

Public ClinicalTrials.gov record NCT02594124. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 5:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443

Study identification

NCT ID
NCT02594124
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
292 participants

Conditions and interventions

Interventions

  • nusinersen Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 3, 2015
Primary completion
Aug 20, 2023
Completion
Aug 20, 2023
Last update posted
Oct 21, 2024

2015 – 2023

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
David Geffen School of Medicine at UCLA Los Angeles California 90095-8344
Stanford University School of Medicine Palo Alto California 94305
Children's Hospital Colorado Aurora Colorado 80045
Connecticut Children's Medical Center Hartford Connecticut 06106
Nemours Children's Clinic Orlando Florida 32827
Ann & Robert H. Lurie Children's Hospital of Chicago New York Illinois 60611
The Johns Hopkins Hospital Baltimore Maryland 21287
Boston Children's Hospital Boston Massachusetts 02115
Gillette Children's Specialty Healthcare Saint Paul Minnesota 55101
Washington University School of Medicine St Louis Missouri 63110
Columbia University Medical Center New York New York 10032
Duke University School of Medicine Durham North Carolina 27710
Duke University School of Medicine Miyagi North Carolina 27710
Oregon Health Sciences University Durham Oregon 97239
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Medical Center Dallas Texas 75235
University of Utah Obu, Aichi Utah 84112
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02594124, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2024 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02594124 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →